Who We Are

The New Jersey Life Sciences Vendors Alliance (NJLSVA) is a coalition of businesses, individuals and academia who provide goods and services to New Jersey’s life sciences companies.

The NJLSVA was founded to educate suppliers on trends in industry procurement and public policy that affects the life sciences industry.

Choose NJ’s RFP Watch

Choose New Jersey’s RFP Watch provides up-to-date information on business opportunities throughout the Garden State at a cost that is affordable for all companies – with a place of business in New Jersey – large and small.

To learn more click here

Opioids

BIO Releases Plan to Unleash Innovation in Fight Against Opioid Abuse and Addiction

Washington, DC, November 9, 2017 — The Biotechnology Innovation Organization (BIO) on November 2 released a set of priorities for unleashing the power of innovation to develop solutions to prescription opioid abuse and addiction.

Many of BIO’s priorities align with recommendations put forth on November 1 by the President’s Commission on Combating Drug Addiction and the Opioid Crisis, including proposals to ensure that patients have comprehensive access to appropriate treatments, and increasing support for basic research to improve our understanding of the biology of pain and addiction.

Such recommendations outlined by the Commission include: Continue reading

NJ Attorney General Announces Suit Against Purdue Pharma Alleging Scheme to ‘Mainstream’ Addictive Opioids for Profit

NJ Attorney General Christopher Porrino

Trenton, NJ, November 1, 2017 — Attorney General Christopher S. Porrino announced yesterday that the State has filed a five-count lawsuit against Purdue Pharma L.P., alleging a “direct” link between New Jersey’s opioid crisis and a push by Purdue to boost profits by deceptively marketing addictive medications and exploiting vulnerable new markets, such as the elderly and the “opioid-naïve.”

The lawsuit charges Purdue with widespread deception about the risks and benefits of these dangerously addictive pain medications.

“When we point the finger of blame for the deadly epidemic that has killed thousands in New Jersey, Purdue is in the bullseye of the target,” said Attorney General Porrino on Tuesday. “[M]y office took the first step toward holding them legally and financially responsible for their deception.” Continue reading

HINJ, PhRMA, Others Challenge NJ Attorney General’s Push to Limit Compensation to Prescribing Doctors

Dean J. Paranicas, President and Chief Executive Officer, HINJ

Trenton, NJ, October 23, 2017 — WHYY Public Radio Philadelphia’s Joe Hernandez reports that, in a new push to fight the opioid crisis, New Jersey officials are trying to stop the flow of legal but highly addictive painkillers at the source: doctors.

A proposed rule change by N.J. Attorney General Christopher Porrino would restrict the amount of money and other compensation drug companies can give out to doctors and other prescribers.  In doing so, state officials hope medical professionals will feel less pressure to prescribe opioids created and sold by the same companies that ply them with gifts and food.

But at a Thursday public hearing in Newark, representatives of the state’s pharmaceutical and medical industries criticized the potential rule change, questioning why it would apply to all drugs and claiming it would damage patient care and drive providers out of state. Continue reading

PhRMA Announces Support for Seven-Day Script Limit on Opioid Medicines for Acute Pain

Washington, DC, October 3, 2017Pharmaceutical Research and Manufacturers of America (PhRMA) President and CEO Stephen J. Ubl on September 27 issued the following statement regarding patient access to opioid medications:

“As part of our commitment to advancing a multifaceted solution to address the opioid crisis, today PhRMA is announcing it supports policies limiting the supply of opioids to seven days for acute pain treatment.

“We are taking this step because we believe the worsening opioid epidemic demands additional solutions, with new protections for patients. Continue reading

Gov. Christie, Pharma Executives and Federal Leaders Discuss Public-Private Partnership to Address Opioid Epidemic

Governor Chris Christie

Trenton, NJ, September 19, 2017 — Governor Chris Christie, chairman of the President’s Commission on Combating Drug Addiction and the Opioid Crisis, yesterday joined Kellyanne Conway, Counselor to the President, and Former U.S. Rep. Patrick Kennedy, a commission member, in a roundtable at the War Memorial with leaders of the pharmaceutical industry, the National Institutes of Health (NIH) and the U.S. Food and Drug Administration (FDA) to advance a public-private partnership that can address America’s epidemic of addiction.

Governor Christie said, “The public and private sectors must join together to address this public health crisis and act quickly to stop an epidemic delivering a death toll equivalent to America enduring another 9-11 attack every two and a half weeks.” Continue reading

White House Opioid Commission Urges Trump: ‘Declare a National Emergency’ on Drug Overdoses; Chaired by Gov. Christie

Washington, DC, August 1, 2017 — Christopher Ingraham reports in The Washington Post that the President’s Commission on Combating Drug Addiction and the Opioid Crisis, chaired by Gov. Chris Christie, issued a preliminary report on Monday stating that its “first and most urgent recommendation” is for the president to “declare a national emergency under either the Public Health Service Act or the Stafford Act.”

“With approximately 142 Americans dying every day,” the report notes, “America is enduring a death toll equal to September 11th every three weeks.” Continue reading

Gov. Christie Reportedly Will Join White House Opioid Effort; Part of Effort Led by Jared Kushner

Governor Chris Christie

Washington, DC, March 28, 2017 — The Associated Press reports that Gov. Chris Christie is expected to join a White House effort to combat opioid abuse.

A White House official said Monday that the governor would work on an opioid task force that will be announced later this week.  The official spoke on the condition of anonymity to discuss the plans in advance.

The Governor has dedicated his final year in office to curbing heroin and prescription drug addiction in New Jersey, advancing an ambitious policy agenda. Continue reading

Rutgers Interview: New Treatment Delivery Methods of Medication for Opioid Addiction Show Promise

Dr. Petros Levounis

New Brunswick, NJ, March 3, 2017 — Rutgers Today’s Patti Verbanas spoke to Petros Levounis, professor and chair of the Department of Psychiatry at Rutgers New Jersey Medical School and a member of the board of directors at the American Society of Addiction Medicine, about recent advancements in opioid treatment delivery methods and the most effective combination of therapies for recovery.

Every day, 91 Americans die from an opioid overdose, according to the Centers for Disease Control and Prevention.  Nationwide, physicians and legislators are ramping up efforts to stem the escalating heroin and prescription opioid addiction crisis. Continue reading

Gov. Christie Signs Executive Order Declaring Opioid Drug Abuse a Public Health Crisis; Creates Drug Abuse Task Force

Governor Chris Christie

Governor Chris Christie

Trenton, NJ, January 18, 2017 — Intensifying his Administration’s commitment in the fight against substance abuse, Governor Chris Christie yesterday signed Executive Order 219 declaring the opioid epidemic a public health crisis in New Jersey.

The action requires the marshalling of all appropriate resources to combat its harmful effects on state citizens.

“We must take aggressive action to get this insidious crisis under control so I am calling together all resources of state government in order to save lives,” said Governor Christie. Continue reading

Governor Christie Delivers 2017 State of the State Address; Focus Is on Combatting Drug Addiction

Governor Chris Christie

Governor Chris Christie

Trenton, NJ, January 10, 2017Governor Chris Christie delivered his 2017 State of the State Address this afternoon before members of the State Legislature. 

The following is the Governor’s address as Prepared for Delivery today:

This is the seventh time I have had the honor to step before the Legislature and the people of New Jersey to perform one of my duties as Governor. Article V, Section I, Paragraph 12 creates the constitutional requirement to report on the State of the State. As the one person independently elected by all New Jerseyans to state government, the Governor is the only person truly able to give the people this report.

For me, service to the people of this state has been my central responsibility every day of my life for the last fifteen years, first as U.S. Attorney and now as Governor. As I enter my eighth year as Governor, it is my honor and privilege to report on the State of the State I call home for me and my family. Continue reading